Literature DB >> 22361929

Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus.

Ja-Lok Ku1, Kyung-Hee Kim, Jin-Sung Choi, Sung-Hee Kim, Young-Kyoung Shin, Hee Jin Chang, Jae-Moon Bae, Young-Woo Kim, Jun Ho Lee, Han-Kwang Yang, Woo-Ho Kim, Seung-Yong Jeong, Jae-Gahb Park.   

Abstract

We report the characterization of six new gastric carcinoma cell lines (designated NCC-19, NCC-20, NCC-24, NCC-59, SNU-1750 and SNU-1967) established from primary tumor samples of Korean patients. Four cell lines grew as adherent monolayers, one as both adherent and floating cell clumps and one as floating cell aggregates. The cell phenotypes, including the histopathology of the primary tumors and in vitro growth characteristics, were determined. We also performed molecular characterization, including DNA fingerprinting analysis and abnormalities of K-ras, p53, β-catenin, and TGF-βRII genes by PCR-SSCP and sequencing analyses. Population doubling times varied from 47-135 h. All cell lines showed relatively high viability, absence of mycoplasma or bacteria contamination and genetic heterogeneity by DNA fingerprinting analysis. Three lines had p53 mutations; one line had mutations in codon 13 (Gly13Asp) in K-ras and no line had a β-catenin mutation. NCC-59 cell line had a -1-bp mutation in 10-bp poly deoxy adenine repeat tract of the TGF-βRII gene. Moreover, NCC-24 gastric cancer cell line was found to be infected with Epstein-Barr virus (EBV). EBV infection was also shown in the original carcinoma tissue of the NCC-24 cell line. These well-characterized six gastric cancer cell lines should serve as useful tools for investigating the biological characteristics of gastric cancer and, in particular, NCC-24 may serve as a valuable model system to clarify the precise role of EBV in gastric carcinogenesis.

Entities:  

Mesh:

Year:  2012        PMID: 22361929     DOI: 10.1007/s13402-012-0073-9

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  28 in total

1.  p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.

Authors:  T Matozaki; C Sakamoto; T Suzuki; K Matsuda; T Uchida; O Nakano; K Wada; H Nishisaki; Y Konda; M Nagao
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

2.  Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.

Authors:  D Vallböhmer; S R DeMeester; J H Peters; D S Oh; H Kuramochi; D Shimizu; J A Hagen; K D Danenberg; P V Danenberg; T R DeMeester; P T Chandrasoma
Journal:  Dis Esophagus       Date:  2006       Impact factor: 3.429

3.  Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Authors:  A F Gazdar; H K Oie
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice.

Authors:  Y Iwasaki; J M Chong; Y Hayashi; R Ikeno; K Arai; M Kitamura; M Koike; K Hirai; M Fukayama
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Characteristics of cell lines established from human gastric carcinoma.

Authors:  J G Park; H Frucht; R V LaRocca; D P Bliss; Y Kurita; T R Chen; J G Henslee; J B Trepel; R T Jensen; B E Johnson
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

7.  Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.

Authors:  K Yanagihara; T Seyama; M Tsumuraya; N Kamada; K Yokoro
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice.

Authors:  Kazuyoshi Yanagihara; Hiromi Tanaka; Misato Takigahira; Yoshinori Ino; Yoshiyuki Yamaguchi; Tetsuya Toge; Kokichi Sugano; Setsuo Hirohashi
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

9.  Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers.

Authors:  S L Lu; W C Zhang; Y Akiyama; T Nomizu; Y Yuasa
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

10.  Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation.

Authors:  T Kihana; H Tsuda; T Hirota; Y Shimosato; H Sakamoto; M Terada; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1991-03
View more
  7 in total

1.  Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.

Authors:  Michael J Strong; Thomas Laskow; Hani Nakhoul; Eugene Blanchard; Yaozhong Liu; Xia Wang; Melody Baddoo; Zhen Lin; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Authors:  Kie-Kyon Huang; Vikrant Kumar; Kalpana Ramnarayanan; Deniz Demircioglu; Zhisheng Her; Raghav Sundar; Xuewen Ong; Zul Fazreen Bin Adam Isa; Manjie Xing; Angie Lay-Keng Tan; David Wai Meng Tai; Su Pin Choo; Weiwei Zhai; Jia Qi Lim; Meghna Das Thakur; Luciana Molinero; Edward Cha; Marcella Fasso; Monica Niger; Filippo Pietrantonio; Jeeyun Lee; Anand D Jeyasekharan; Aditi Qamra; Radhika Patnala; Arne Fabritius; Mark De Simone; Joe Yeong; Cedric Chuan Young Ng; Sun Young Rha; Yukiya Narita; Kei Muro; Yu Amanda Guo; Anders Jacobsen Skanderup; Jimmy Bok Yan So; Wei Peng Yong; Qingfeng Chen; Jonathan Göke; Patrick Tan
Journal:  Gut       Date:  2021-08-25       Impact factor: 31.793

Review 3.  Epstein-barr virus in gastric carcinoma.

Authors:  Jun Nishikawa; Hironori Yoshiyama; Hisashi Iizasa; Yuichi Kanehiro; Munetaka Nakamura; Junichi Nishimura; Mari Saito; Takeshi Okamoto; Kouhei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Atsunori Oga; Hideo Yanai; Isao Sakaida
Journal:  Cancers (Basel)       Date:  2014-11-07       Impact factor: 6.639

4.  Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib.

Authors:  Kwai Fung Hui; Po Ling Yeung; Alan K S Chiang
Journal:  Oncotarget       Date:  2016-01-26

5.  Establishment and characterization of a new gastric cancer cell line, XGC-1.

Authors:  Jigui Peng; Hao Xu; Jianchun Cai
Journal:  Cancer Cell Int       Date:  2020-09-05       Impact factor: 5.722

6.  Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine.

Authors:  Xiangyu Ke; Qingsong Qin; Tianyi Deng; Yueyan Liao; Shou-Jiang Gao
Journal:  Cancers (Basel)       Date:  2020-02-05       Impact factor: 6.639

7.  Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.

Authors:  Hae Ryung Chang; Hee Seo Park; Young Zoo Ahn; Seungyoon Nam; Hae Rim Jung; Sungjin Park; Sang Jin Lee; Curt Balch; Garth Powis; Ja-Lok Ku; Yon Hui Kim
Journal:  BMC Cancer       Date:  2016-03-09       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.